Helius Medical Technologies Inc buy melinda
Start price
18.11.18
/
50%
€243.95
Target price
07.01.19
€348.25
Performance (%)
11.62%
End price
07.01.19
€272.30
Summary
This prediction ended on 07.01.19 with a price of €272.30. The BUY prediction by melinda finished with a performance of 11.62%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Helius Medical Technologies Inc | - | - | - | - |
| iShares Core DAX® | -0.205% | 2.528% | 16.157% | 18.725% |
| iShares Nasdaq 100 | 1.613% | 4.733% | 30.626% | 56.133% |
| iShares Nikkei 225® | -0.740% | 0.396% | 9.039% | 5.948% |
| iShares S&P 500 | 0.267% | 2.720% | 26.333% | 47.720% |
Comments by melinda for this prediction
In the thread Helius Medical Technologies Inc diskutieren
SecteurEquipement et technologie médicale avancés
Operates as a medical technology company focused on neurological wellness
Helius Medical Technologies, Inc. is a medical technology company, which engages in the development of products for the treatment of neurological symptoms caused by disease and trauma.
It focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself.
The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Helius Medical Technologies, Inc. is a medical technology company, which engages in the development of products for the treatment of neurological symptoms caused by disease and trauma.
It focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself.
The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Nombre d'employés : 50 personnes.
Stopped prediction by melinda for Helius Medical Technologies Inc
Helius Medical Technologies Inc
Start price
Target price
Perf. (%)
€13.50
06.01.21
06.01.21
€0.60
06.01.22
06.01.22
-65.93%
07.01.22
07.01.22
